Xu Che

2.6k total citations
81 papers, 1.2k citations indexed

About

Xu Che is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xu Che has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 31 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xu Che's work include Pancreatic and Hepatic Oncology Research (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Xu Che is often cited by papers focused on Pancreatic and Hepatic Oncology Research (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Xu Che collaborates with scholars based in China, United States and United Kingdom. Xu Che's co-authors include Wen Tan, Chengfeng Wang, Chen Wu, Dongxin Lin, Dianke Yu, Liming Huang, Jian Xu, Hui Li, Tongwen Zhang and Li Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xu Che

73 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Che China 15 603 523 373 243 188 81 1.2k
Tianyi Gao China 20 777 1.3× 598 1.1× 268 0.7× 111 0.5× 143 0.8× 47 1.3k
Chaohui Zuo China 17 422 0.7× 273 0.5× 169 0.5× 112 0.5× 126 0.7× 45 823
Nicolai A. Schultz Denmark 14 571 0.9× 501 1.0× 541 1.5× 412 1.7× 125 0.7× 40 1.3k
Hye Won Lee South Korea 16 468 0.8× 387 0.7× 189 0.5× 90 0.4× 110 0.6× 78 964
Haijing Deng China 15 334 0.6× 233 0.4× 227 0.6× 160 0.7× 209 1.1× 19 994
Daniel Lin United States 16 327 0.5× 290 0.6× 235 0.6× 261 1.1× 220 1.2× 50 1.0k
Nobuhiro Tsuchiya Japan 10 308 0.5× 202 0.4× 236 0.6× 83 0.3× 125 0.7× 28 769
Guobin Wu China 16 448 0.7× 270 0.5× 184 0.5× 100 0.4× 83 0.4× 35 909
Agda Karina Eterovic United States 14 389 0.6× 297 0.6× 487 1.3× 154 0.6× 171 0.9× 30 1.0k

Countries citing papers authored by Xu Che

Since Specialization
Citations

This map shows the geographic impact of Xu Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Che more than expected).

Fields of papers citing papers by Xu Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Che. The network helps show where Xu Che may publish in the future.

Co-authorship network of co-authors of Xu Che

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Che. A scholar is included among the top collaborators of Xu Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Che. Xu Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Lixia, et al.. (2025). PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1. Life Sciences. 372. 123631–123631. 1 indexed citations
2.
3.
Wei, Zhicheng, Bowen Xu, Jianping Chang, et al.. (2024). MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1. Cancer Cell International. 24(1). 129–129. 1 indexed citations
4.
5.
6.
7.
Lin, Xu, et al.. (2021). Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 11. 757498–757498. 4 indexed citations
8.
9.
Zhang, Wei, et al.. (2021). Safety and effectiveness of open pancreaticoduodenectomy in adults aged 70 or older: A meta-analysis. Journal of Geriatric Oncology. 12(7). 1136–1145. 7 indexed citations
10.
Ren, Hua, Zhicheng Wei, Yanxia Sun, et al.. (2021). ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM. Frontiers in Oncology. 11. 714264–714264. 10 indexed citations
11.
Che, Xu, et al.. (2019). Expression of Lin28 is correlated with prognosis and expression of HER-2 and steroid receptors in breast cancer. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Li, Ye‐Xiong, Qinfu Feng, Jing Jin, et al.. (2019). Experts’ consensus on intraoperative radiotherapy for pancreatic cancer. Cancer Letters. 449. 1–7. 12 indexed citations
13.
Rucki, Agnieszka A., Qian Xiao, Stephen Muth, et al.. (2017). Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. Molecular Cancer Therapeutics. 16(11). 2399–2409. 28 indexed citations
14.
Zhang, Shuisheng, Cuiling Zheng, Yingtai Chen, et al.. (2017). Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: A retrospective study in China. International Journal of Surgery. 43. 145–154. 11 indexed citations
15.
Jiang, Qinglong, Chengfeng Wang, Yantao Tian, et al.. (2017). Body mass index does not affect the survival of pancreatic cancer patients. World Journal of Gastroenterology. 23(34). 6287–6287. 10 indexed citations
16.
Chen, Yingtai, Xu Che, Jianwei Zhang, et al.. (2016). Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer. Medicine. 95(38). e4861–e4861. 16 indexed citations
17.
Tang, Xiaolong, et al.. (2016). The Clinicopathological Features and Long-Term Survival Outcomes of Mucinous Gastric Carcinoma: a Consecutive Series of 244 Cases from a Single Institute. Journal of Gastrointestinal Surgery. 20(4). 693–699. 14 indexed citations
18.
Liang, Jianwei, Zhi‐Zhou Shi, Xu Che, et al.. (2014). Identification of Genomic Alterations in Pancreatic Cancer Using Array-Based Comparative Genomic Hybridization. PLoS ONE. 9(12). e114616–e114616. 21 indexed citations
19.
Zhao, Ping, Ye‐Xiong Li, Yi Shan, et al.. (2010). [Role of 125I seed implantation in treatment of unresectable pancreatic cancer].. PubMed. 90(2). 92–5. 5 indexed citations
20.
Shan, Yi, Xu Che, Dongbing Zhao, et al.. (2007). [Surgical management of ovarian metastasis from colorectal cancer].. PubMed. 10(2). 146–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianyi Gao Breakdown of academic impact, for papers by Chaohui Zuo Breakdown of academic impact, for papers by Nicolai A. Schultz Breakdown of academic impact, for papers by Hye Won Lee Breakdown of academic impact, for papers by Haijing Deng Breakdown of academic impact, for papers by Daniel Lin Breakdown of academic impact, for papers by Nobuhiro Tsuchiya Breakdown of academic impact, for papers by Guobin Wu Breakdown of academic impact, for papers by Agda Karina Eterovic
Rankless by CCL
2026